Compound Summary
cilnidipine
Compound Information
cilnidipine
Compound Name: | cilnidipine |
Compound CID: | 5282138 |
Synonyms: | cilnidipine 132203-70-4 Cinalong FRC-8653 Siscard More... |
Iupac Name: | 3-O-(2-methoxyethyl) 5-O-[(E)-3-phenylprop-2-enyl] 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate |
InChI: | InChI=1S/C27H28N2O7/c1-18-23(26(30)35-14-8-11-20-9-5-4-6-10-20)25(21-12-7-13-22(17-21)29(32)33)24(19(2)28-18)27(31)36-16-15-34-3/h4-13,17,25,28H,14-16H2,1-3H3/b11-8+ |
InChIKey: | KJEBULYHNRNJTE-DHZHZOJOSA-N |
Canonical Smiles: | CC1=C(C(C(=C(N1)C)C(=O)OCC=CC2=CC=CC=C2)C3=CC(=CC=C3)[N+](=O)[O-])C(=O)OCCOC |
Isomeric Smiles: | CC1=C(C(C(=C(N1)C)C(=O)OC/C=C/C2=CC=CC=C2)C3=CC(=CC=C3)[N+](=O)[O-])C(=O)OCCOC |
Molecular Weight: | 492.5 |
Molecular Formula: | C27H28N2O7 |
Compound Structure
2D Structure:
3D Structure:
Computed Properties
cilnidipine
Molecular Weight: | 492.5 |
Molecular Formula: | C27H28N2O7 |
Hydrogen Bond Donor Count: | 1 |
Hydrogen Bond Acceptor Count: | 8 |
Rotatable Bond Count: | 11 |
Heavy Atom Count: | 36 |
Complexity: | 896 |
Synonyms
cilnidipine
| cilnidipine | cilnidipine |
|---|---|
cilnidipine |
132203-70-4 |
Cinalong |
FRC-8653 |
Siscard |
Atelec |
FRC 8653 |
3-cinnamyl 5-(2-methoxyethyl) 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate |
CHEBI:31399 |
(+-)-(E)-Cinnamyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate |
UNII-4LNU2SU262 |
4LNU2SU262 |
UNII-S85436ZG85 |
MFCD00865853 |
S85436ZG85 |
2-methoxyethyl (2E)-3-phenylprop-2-en-1-yl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate |
Cilnidipine INN |
NCGC00162150-01 |
Cinaldipine |
DSSTox_CID_26309 |
DSSTox_RID_81530 |
DSSTox_GSID_46309 |
1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid 2-methoxyethyl (2E)-3-phenyl-2-propenyl ester |
(E)-Cinnamyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate |
Atelec (TN) |
CAS-132203-70-4 |
SR-05000001454 |
Cilnidipine- Bio-X |
Cilnidipine, (+)- |
Cilnidipine, (-)- |
Cilnidipine (JP17/INN) |
SCHEMBL25550 |
3-O-(2-methoxyethyl) 5-O-(E)-3-phenylprop-2-enyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate |
CHEMBL452076 |
GTPL7767 |
DTXSID0046309 |
CHEBI:91506 |
HMS2089J07 |
HMS3261E06 |
HMS3413L13 |
HMS3677L13 |
HMS3715N17 |
HMS3884K09 |
BCP22689 |
EBD38396 |
Tox21_112001 |
Tox21_500422 |
AC-270 |
BDBM50101813 |
s1293 |
STK623341 |
AKOS005558085 |
Tox21_112001_1 |
CCG-221188 |
CCG-221726 |
Cilnidipine, >=98% (HPLC), powder |
CS-1133 |
DB09232 |
KS-1294 |
LP00422 |
SDCCGSBI-0633712.P001 |
NCGC00162150-02 |
NCGC00162150-03 |
NCGC00162150-04 |
NCGC00162150-16 |
NCGC00261107-01 |
(+)-FRC-8653 |
(-)-FRC-8653 |
3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, 2-methoxyethyl 3-phenyl-2-propenyl ester, (E)-(+-)- |
BC164309 |
H738 |
HY-17404 |
LS-15175 |
AB0004990 |
SW219784-1 |
D01173 |
T70209 |
AB01274755-01 |
AB01274755-02 |
AB01274755_03 |
FRC-8653; FRC 8653; FRC8653 |
203C704 |
Q731525 |
J-006141 |
SR-05000001454-1 |
SR-05000001454-2 |
BRD-A07875874-001-01-6 |
F2173-0669 |
1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic Acid 2-Methoxyethyl (2E)-3-Phenyl-2-propenyl Ester / 2-Methoxyethyl (2E)-3-Phenyl-2-propenyl 1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate |
132295-21-7 |
132338-87-5 |
2-Methoxyethyl (2E)-3-Phenyl-2-propenyl 1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate |
3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, 2-methoxyethyl 3-phenyl-2-propenyl ester, (E)-(+)- |
3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, 2-methoxyethyl 3-phenyl-2-propenyl ester, (E)-(-)- |
3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, 3-(2-methoxyethyl) 5-(2E)-3-phenyl-2-propen-1-yl ester |
O3-(2-methoxyethyl) O5-(3-phenylprop-2-enyl) 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate |
Experimental Data
cilnidipine
| Species | Dose | Unit | Control(Avg days) | Treatment(Avg days) | Avg/Med Lifespan Change(%) | Control(Max days) | Treatment(Max days) | Max Lifespan Change(%) | Significant | Strain | Gender | PubMed | Avg/Med Lifespan Change tab |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Caenorhabditis elegans | 33.000000000000000 | umol/L | -8.000000000000000 | NS | N2 | 24134630 | Inactive |
Experimental Data Visualization
cilnidipine
Statistics Data
cilnidipine
| Species | Avg/Med Lifespan Change(%) | Max Lifespan Change(%) | Count Reference | Count Data point |
|---|---|---|---|---|
| Caenorhabditis elegans | -8.000000000000000 | 1 | 1 |
Statistics Data Visualization
cilnidipine
